Chlorpheniramine Polistirex
A sustained-release form of chlorpheniramine complexed with a polymer ion exchange resin that slows its absorption and extends its duration of action to approximately 12 hours. It provides prolonged antihistamine relief for allergy and cold symptoms with less frequent dosing. It is found in extended-release combination cold and cough products.
分子量
274.7900 g/mol
LogP
3.40
TPSA
16.10 Ų
リピンスキーの五則
適合
作用機序
Competitively blocks histamine H1 receptors on effector cells, preventing histamine-mediated vasodilation, increased vascular permeability, bronchoconstriction, and pruritus. First-generation agents also cross the blood-brain barrier, causing sedation.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Competitively blocks histamine H1 receptors on effector cells, preventing histamine-mediated vasodilation, increased vascular permeability, bronchoconstriction, and pruritus. First-generation agents also cross the blood-brain barrier, causing sedation.
2D構造
Cite this structure
Embed this structure
SMILES
CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2
InChI
InChI=1S/C16H19ClN2/c1-19(2)12-10-15(16-5-3-4-11-18-16)13-6-8-14(17)9-7-13/h3-9,11,15H,10,12H2,1-2H3
Molecular Formula
C16H19ClN2
HBD / HBA
- / 2
回転可能結合数
5
重原子数
19
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
よくある質問
A sustained-release form of chlorpheniramine complexed with a polymer ion exchange resin that slows its absorption and extends its duration of action to approximately 12 hours. It provides prolonged antihistamine relief for allergy and cold symptoms with less frequent dosing. It is found in extended-release combination cold and cough products.
Competitively blocks histamine H1 receptors on effector cells, preventing histamine-mediated vasodilation, increased vascular permeability, bronchoconstriction, and pruritus. First-generation agents also cross the blood-brain barrier, causing sedation.
Yes, Chlorpheniramine Polistirex is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201659. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 2725. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="chlorpheniramine-polistirex"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/chlorpheniramine-polistirex/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/chlorpheniramine-polistirex/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/chlorpheniramine-polistirex/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="chlorpheniramine-polistirex"></drugfyi-drug>